Market revenue in 2023 | USD 311.0 million |
Market revenue in 2030 | USD 707.2 million |
Growth rate | 12.5% (CAGR from 2023 to 2030) |
Largest segment | Dna chips |
Fastest growing segment | Lab-on-chip |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Tissue Arrays, Cell Arrays, DNA Chips, Lab-on-chip, Protein Chips |
Key market players worldwide | Agilent Technologies Inc, PerkinElmer, Illumina Inc, Bio-Rad Laboratories Inc, Standard BioTools Inc, GE HealthCare Technologies Inc Common Stock, Thermo Fisher Scientific Inc, Qiagen NV, Randox |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biochip market will help companies and investors design strategic landscapes.
Dna chips was the largest segment with a revenue share of 38.78% in 2023. Horizon Databook has segmented the France biochip market based on tissue arrays, cell arrays, dna chips, lab-on-chip, protein chips covering the revenue growth of each sub-segment from 2018 to 2030.
France’s biochip market is projected to grow at a lucrative rate during the forecast period, owing to high cancer prevalence and the increasing burden of chronic diseases on the healthcare industry. In October 2022, the My Personal Breast Cancer Screening (MyPeBS) clinical trial was conducted in Belgium, which aimed to evaluate a breast cancer screening plan based on individual risk.
Similarly, in June 2021, Bayer and ZERO—The End of Prostate Cancer announced the launch of a national prostate cancer education program to increase awareness about cancer screening & treatment. Such factors are expected to boost the country’s market in the coming years.
Moreover, supportive government legislation and funding for research projects are projected to support the country’s market in the coming years. For instance, in February 2023, Agence Nationale De La Recherche made significant efforts to strengthen the role of DNA microarrays in developing novel diagnostics.
Horizon Databook provides a detailed overview of country-level data and insights on the France biochip market, including forecasts for subscribers. This country databook contains high-level insights into France biochip market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account